Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

E-ISSN： 1445-2197|85|5|315-320

ISSN： 1445-1433

Source： ANZ JOURNAL OF SURGERY, Vol.85, Iss.5, 2015-05, pp. : 315-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Factors in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy: Towards a Quantification of Residual Disease

Oncology, Vol. 88, Iss. 5, 2015-01 ,pp. : 261-272

Karger

Access to resources Recommend Favorite

Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

Macroscopic handling and reporting of breast cancer specimens pre‐ and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches

HISTOPATHOLOGY, Vol. 67, Iss. 3, 2015-09 ,pp. : 279-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Advances in the adjuvant and neoadjuvant treatment of breast cancer

By Briest Susanne Stearns Vered

Women's Health, Vol. 3, Iss. 3, 2007-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite